Pervasive Developmental Disorder NOS Completed Phase 3 Trials for Aripiprazole (DB01238)

Also known as: Pervasive Developmental Disorder / Pervasive Developmental Disorders / Autistic continuum / Pervasive Development Disorders / Atypical autism / Autism spectrum disorder

IndicationStatusPhase
DBCOND0046531 (Pervasive Developmental Disorder NOS)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00870727Study of Aripiprazole in the Treatment of Pervasive Developmental DisordersTreatment